| Title | FLT3 Inhibitor Maintenance After Allogeneic Transplantation: Is a Placebo-Controlled, Randomized Trial Ethical? |
| Publication Type | Journal Article |
| Year of Publication | 2019 |
| Authors | Levis, MJ, Bin Chen, Y-, Hamadani, M, Horowitz, MM, Jones, RJ |
| Corporate Authors | Blood and Marrow Transplant Clinical Trials Network |
| Journal | J Clin Oncol |
| Volume | 37 |
| Issue | 19 |
| Pagination | 1604-1607 |
| Date Published | 2019 07 01 |
| ISSN | 1527-7755 |
| Keywords | Antineoplastic Agents, Ethics, Medical, fms-Like Tyrosine Kinase 3, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Myeloid, Acute, Mutation, Neoplasm Recurrence, Local, Prognosis, Randomized Controlled Trials as Topic, Research Design, Transplantation, Homologous, Treatment Outcome |
| DOI | 10.1200/JCO.19.00321 |
| Alternate Journal | J Clin Oncol |
| PubMed ID | 31034300 |
| PubMed Central ID | PMC6804888 |
| Grant List | U24 CA076518 / CA / NCI NIH HHS / United States U24 HL138660 / HL / NHLBI NIH HHS / United States |
